Screener
Elevance Health ELV Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 89.1%+0.4pp | 89.2%+0.6pp | 89.4%+0.5pp | 88.9%-0.5pp | 88.7%-0.8pp | |
| Net margin | 2.5%-0.4pp | 2.6%-0.6pp | 2.8%-0.5pp | 2.8%-0.8pp | 2.8%-1.1pp | |
| Returns | ||||||
| Return on equity | 11.2%-1.3pp | 12.1%-2.1pp | 13.3%-1.5pp | 12.6%-3.0pp | 12.5%-4.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.6×0.0× | 1.6×0.0× | 1.7×+0.1× | 1.6×+0.1× | 1.6×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.5×+0.1× | 1.5×0.0× | 1.5×+0.1× | 1.6×+0.1× | 1.4×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.7×0.0× | 0.7×+0.1× | 0.7×0.0× | 0.7×+0.1× | 0.7×+0.1× | |
| Valuation | ||||||
| Market capitalization | $81.51B+31.7% | $64.31B-34.7% | $77.91B-8.9% | $72.76B-39.7% | $85.05B-32.4% | |
| Price / earnings | 16.4×+4.9× | 12.3×-4.4× | 13.8×-0.5× | 13.2×-5.7× | 15.9×-2.9× | |
| Price / sales | 0.4×+0.1× | 0.3×-0.2× | 0.4×-0.1× | 0.4×-0.3× | 0.4×-0.3× | |
| Price / book | 1.8×+0.4× | 1.5×-0.9× | 1.8×-0.3× | 1.7×-1.1× | 1.9×-1.0× | |
| Dividend yield | 1.8%-0.6pp | 2.4%+0.8pp | 2%+0.2pp | 2.1%+0.9pp | 1.8%+0.6pp |
FAQ
- Where do Elevance Health's ratios come from?
- Every ratio is computed from Elevance Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
